Article

Multiple factors determine residual refractive error

Attention to a host of preoperative and intraoperative factors can minimize the risk of residual refractive error after cataract surgery, but when a refractive surprise occurs, there are multiple variables to consider before deciding on intervention according to one expert.

According to national benchmarks, cataract surgeons should aim for the achieved refraction to be within 0.5 D of the target about 55% of the time and within 1.0 D in about 85% of cases.

Dr. Arbisser said that, in her hands and based on analysis of data for all comers, she well exceeds these targets with 85% of eyes achieving a refraction ±0.5 D of the target and 99.2% having a RRE <1.0 D.

Preventive strategies

"Although we cannot bill for this procedure, it may be worth obtaining an axial length measurement with [partial coherence interferometry] when patients present with early cataractous changes, even if surgery is not yet contemplated, just in case the patient does not return before the cataract becomes super dense," Dr. Arbisser said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.